426 related articles for article (PubMed ID: 30727877)
1. Cancer-on-a-chip for Drug Screening.
Lee IC
Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
[TBL] [Abstract][Full Text] [Related]
2. Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapy.
Astolfi M; Péant B; Lateef MA; Rousset N; Kendall-Dupont J; Carmona E; Monet F; Saad F; Provencher D; Mes-Masson AM; Gervais T
Lab Chip; 2016 Jan; 16(2):312-25. PubMed ID: 26659477
[TBL] [Abstract][Full Text] [Related]
3. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
4. Organ-on-chip models: Implications in drug discovery and clinical applications.
Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
[TBL] [Abstract][Full Text] [Related]
5. Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.
Chen Y; Gao D; Liu H; Lin S; Jiang Y
Anal Chim Acta; 2015 Oct; 898():85-92. PubMed ID: 26526913
[TBL] [Abstract][Full Text] [Related]
6. Anticancer drug discovery using multicellular tumor spheroid models.
Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
[TBL] [Abstract][Full Text] [Related]
7. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs.
Liu Y; Sakolish C; Chen Z; Phan DTT; Bender RHF; Hughes CCW; Rusyn I
Toxicology; 2020 Dec; 445():152601. PubMed ID: 32980478
[TBL] [Abstract][Full Text] [Related]
8. A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine.
Steinberg E; Friedman R; Goldstein Y; Friedman N; Beharier O; Demma JA; Zamir G; Hubert A; Benny O
Commun Biol; 2023 Nov; 6(1):1157. PubMed ID: 37957280
[TBL] [Abstract][Full Text] [Related]
9. On-chip anticancer drug screening - Recent progress in microfluidic platforms to address challenges in chemotherapy.
Dhiman N; Kingshott P; Sumer H; Sharma CS; Rath SN
Biosens Bioelectron; 2019 Jul; 137():236-254. PubMed ID: 31121461
[TBL] [Abstract][Full Text] [Related]
10. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
11. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
[TBL] [Abstract][Full Text] [Related]
12. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
13. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic technologies for anticancer drug studies.
Valente KP; Khetani S; Kolahchi AR; Sanati-Nezhad A; Suleman A; Akbari M
Drug Discov Today; 2017 Nov; 22(11):1654-1670. PubMed ID: 28684326
[TBL] [Abstract][Full Text] [Related]
15. Organoid and Spheroid Tumor Models: Techniques and Applications.
Gunti S; Hoke ATK; Vu KP; London NR
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
[TBL] [Abstract][Full Text] [Related]
16. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
LaBarbera DV; Reid BG; Yoo BH
Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional microfluidic chip for cancer diagnosis and treatment.
Guo QR; Zhang LL; Liu JF; Li Z; Li JJ; Zhou WM; Wang H; Li JQ; Liu DY; Yu XY; Zhang JY
Nanotheranostics; 2021; 5(1):73-89. PubMed ID: 33391976
[TBL] [Abstract][Full Text] [Related]
18. An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy.
Hachey SJ; Movsesyan S; Nguyen QH; Burton-Sojo G; Tankazyan A; Wu J; Hoang T; Zhao D; Wang S; Hatch MM; Celaya E; Gomez S; Chen GT; Davis RT; Nee K; Pervolarakis N; Lawson DA; Kessenbrock K; Lee AP; Lowengrub J; Waterman ML; Hughes CCW
Lab Chip; 2021 Apr; 21(7):1333-1351. PubMed ID: 33605955
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
20. 3D bioprinting for drug discovery and development in pharmaceutics.
Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
